• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  varespladib sodium
Date Designated:  11/19/2007
Orphan Designation:  Prevention of acute chest syndrome in at-risk patients with sickle cell disease
Orphan Designation Status:  Designated/Withdrawn
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
Anthera Pharmaceuticals, Inc.
25801 Industrial Blvd.
Suite B
Hayward, California 94545
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.